Monitoring kidney function and albuminuria in patients with diabetes.
about
UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy.The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment.Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetesPrevalent Rate of Nonalbuminuric Renal Insufficiency and Its Association with Cardiovascular Disease Event in Korean Type 2 DiabetesDoes albuminuria predict renal risk and/or cardiovascular risk in obese type 2 diabetic patients?Metformin use among individuals at risk for type 2 diabetes.Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).Urinary excretion of high molecular weight adiponectin is an independent predictor of decline of renal function in type 2 diabetes.Improvement in albuminuria in patients with type 2 diabetes after laparoscopic adjustable gastric banding.Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate.Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis.
P2860
Q30651159-14F7A73E-F8FD-4A00-9F25-33365211BCD3Q33845734-25B7EF92-DDD8-4295-B40B-EB329E5BC6A1Q33899286-1A72CF6E-A7A0-4D56-8EDE-0D21AA4E70C6Q34503796-D320B162-5CCA-48C0-A54B-38294A08CDF6Q34891146-25784A67-C98D-47A7-9934-BCCCCFFFB708Q35780861-A7136C16-FE7E-4967-A86F-08BB0D5B7107Q37541414-AD014594-5002-4C4B-8B13-D7A51A38A837Q37587312-DBBC68F9-EE98-4695-9D22-B0923B7E5C96Q37991589-B0895B56-F9A3-4B75-B5A6-136D0291D949Q42272174-91512445-E3E2-4410-9272-6B8DC941C5E4Q43490546-285AFBCC-1054-4E3B-ACBD-263D897979A6Q45795075-9CA590B6-4D4A-4EB1-8AD6-3B96A55C2FF8Q47095989-FD667C3F-AC33-4936-B192-91CE9C24DB12Q48215223-2005EF39-F15A-42B0-B51D-DF5D64480375
P2860
Monitoring kidney function and albuminuria in patients with diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Monitoring kidney function and albuminuria in patients with diabetes.
@ast
Monitoring kidney function and albuminuria in patients with diabetes.
@en
Monitoring kidney function and albuminuria in patients with diabetes.
@nl
type
label
Monitoring kidney function and albuminuria in patients with diabetes.
@ast
Monitoring kidney function and albuminuria in patients with diabetes.
@en
Monitoring kidney function and albuminuria in patients with diabetes.
@nl
prefLabel
Monitoring kidney function and albuminuria in patients with diabetes.
@ast
Monitoring kidney function and albuminuria in patients with diabetes.
@en
Monitoring kidney function and albuminuria in patients with diabetes.
@nl
P2093
P2860
P921
P356
P1433
P1476
Monitoring kidney function and albuminuria in patients with diabetes.
@en
P2093
Heerspink HJ
Holtkamp FA
de Zeeuw D
P2860
P304
P356
10.2337/DC11-S247
P407
P478
34 Suppl 2
P5008
P577
2011-05-01T00:00:00Z